Skip to main content
EAIQ
OTC Trade & Services

Eyeonix AIQ to Pay 30.6M Shares for COMMAND HEALGRID Source Code

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Neutral
Importance info
7
Price
$1.98
Mkt Cap
--
52W Low
$0.008
52W High
$3
52W Position
Off High info
34% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

EAIQ filed a M&A and Partnerships on light trading volume (0.1× avg).

Summary

Eyeonix AIQ's subsidiary signed an MOU to buy the COMMAND HEALGRID source code from Greece-based Eyeonix S.A. for 30.6 million shares, with closing expected this calendar year.


Key Events · M&A and Partnerships · EAIQ

  • MOU to Acquire COMMAND HEALGRID Source Code

    On October 30, 2026, wholly owned subsidiary Eyeonix MedAIQ, Inc. signed a Memorandum of Understanding with Eyeonix S.A. of Greece to acquire all rights to the COMMAND HEALGRID software source code, with MedAIQ assuming ongoing development.

  • Consideration Is 30.6 Million Shares

    The entire purchase price is 30,600,000 shares of Eyeonix AIQ common stock issued to Eyeonix Greece — no cash component disclosed. The filing does not state shares outstanding, so the dilution percentage cannot be calculated from this document.

  • Related-Party Counterparty

    The seller, Eyeonix S.A., shares the Eyeonix name with the issuer and its subsidiary, indicating an affiliated transaction; the filing discloses no independent valuation or fairness opinion for the asset.

  • Closing Targeted This Calendar Year

    The MOU is non-binding and the transaction is expected to finalize in calendar 2026; no specific closing date, conditions, or termination terms were disclosed.


Analysis · EAIQ · Trade & Services

Eyeonix AIQ's wholly owned subsidiary has signed a non-binding MOU to acquire the COMMAND HEALGRID source code from Eyeonix S.A., a Greek company, paying entirely in 30.6 million newly issued shares rather than cash. The share count is the whole story: the company has not disclosed its outstanding share count in this filing, so the dilution cannot be quantified here, but 30.6 million shares is a large absolute block for a $1.98 stock and the counterparty shares the Eyeonix name, making this a related-party deal that warrants scrutiny of the terms. The MOU is not a closed transaction — it is expected to finalize this calendar year, and no valuation, revenue, or asset financials were provided, so investors are being asked to accept a share-funded purchase of an unspecified-value asset on trust.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EAIQ was trading at $1.98 on OTC in the Trade & Services sector. The 52-week trading range was $0.01 to $3.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EAIQ - Latest Insights

EAIQ
Nov 12, 2026, 1:03 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.98
Real-time Price: $1.50 info
Change: -$0.480 (-24%) info
Market Cap: N/A info